ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "phenotypes"

  • Abstract Number: 0478 • ACR Convergence 2021

    Identification of Clinical Phenotypes of Hand Osteoarthritis Using Hierarchical Clustering Method

    Marie Binvignat1, Gabriel Pires1, Nicolas Tchitchek1, Alice Courties2, Felicie Costantino3, David Klatzmann1, Bernard Combe4, Maxime Dougados5, Pascal Richette6, Encarnita Mariotti-Ferrandiz1, Francis Berenbaum7 and Jeremie Sellam8, 1Sorbonne Universite, Paris, France, 2Service de Rhumatologie, AP-HP Hopital Saint-Antoine, Sorbonne Universite, INSERM, Centre de Recherche Saint-Antoine, Paris, France, 3Inserm, Boulogne Billancourt, France, 4CHU Montpellier Montpellier University, Montpellier, France, 5Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 6Lariboisiere Hospital, Paris, France, 7Sorbonne Universit - hopital Saint-Antoine, Paris, France, 8INSERM UMRS_938, Sorbonne Université, St-Antoine Hospital, Paris, France, Paris, France

    Background/Purpose: Hand osteoarthritis (OA) is an heterogenous disease in terms of risk factors, localization and severity. This heterogeneity also applies to the clinical presentation and…
  • Abstract Number: 054 • 2020 Pediatric Rheumatology Symposium

    Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups

    Joseph Massias 1, Eve Smith 1, Michael Beresford 1 and Christian Hedrich1, 1University of Liverpool, Liverpool, United Kingdom

    Background/Purpose: Systemic lupus erythematous (SLE) is a systemic autoimmune/inflammatory condition. Up to 20% of patients develop symptoms before their 18th birthday and are diagnosed with…
  • Abstract Number: 2021 • 2019 ACR/ARP Annual Meeting

    Higher Genetic Risk Load in Patients with More Diverse Manifestations in a Korean Systemic Lupus Erythematosus Cohort

    So-Young Bang1, Eunji Ha 2, Hyuk-Hee Kwon 3, Hyun-Seung Yoo 4, Juyeon Kang 1, Ji-Soong Kim 1, Bora Nam 1, Jung-Min Shin 1, Yeon-Kyung Lee 1, Tae-Han Lee 5, Hye-Soon Lee 6, Kwangwoo Kim 2 and Sang-Cheol Bae 1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 2Kyung Hee University, Seoul, Republic of Korea, 3Hanyang University Hospital, Guri, 4Hanyang University Hospital, Guri, Republic of Korea, 5Hanyang University, Seoul, 6Department of Internal Medicine, Hanyang University Guri Hospital,Hanyang University School of Medicine, Guri, Korea, Guri, Republic of Korea

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with diverse heterogeneous phenotypes. Although many studies of SLE presented estimates of high heritability, impact…
  • Abstract Number: 2850 • 2019 ACR/ARP Annual Meeting

    Exploring Heterogeneity in Rheumatoid Arthritis: Outcomes up to 4 Years of Follow-Up in Patient Clusters Identified by Data-driven Analysis of the BRASS Registry

    Jeffrey Curtis1, Michael Weinblatt 2, Kenneth Saag 1, Vivian Bykerk 3, Christina Charles-Schoeman 4, Stefano Fiore 5, Gregory St John 6, Toshio Kimura 7, Shen Zheng 5, Clifton Bingham 8, Grace Wright 9, Martin Bergman 10, Kamala Nola 11, Daniel Furst 4 and Nancy Shadick 2, 1University of Alabama at Birmingham, Birmingham, AL, 2Brigham and Women's Hospital, Boston, MA, 3Hospital for Special Surgery, New York City, NY, 4University of California, Los Angeles, CA, 5Sanofi Genzyme, Bridgewater, NJ, 6Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 7Regeneron Pharmaceuticals, Inc, Tarrytown, NY, 8Johns Hopkins University, Baltimore, MD, 9Private Practice, New York City, NY, 10Drexel University College of Medicine, Stockholm, Sweden, 11Lipscomb University College of Pharmacy & Health Sciences, Nashville, TN

    Background/Purpose: Patients with rheumatoid arthritis (RA) may share characteristics that relate to their future outcomes. We investigated clinical outcomes over a 4-year follow-up period in…
  • Abstract Number: 1064 • 2018 ACR/ARHP Annual Meeting

    Identification of a Panel of Circulating Proteins Associated to Synovial Pathotypes in Early Rheumatoid Arthritis Patients

    Cristina Ruiz-Romero1, Florencia Picchi2, Patricia Fernández3, Lucia González2, Rebecca Hands4, Valentina Calamia2, Maria Camacho2, Conrad Bessant5, Costantino Pitzalis4 and Francisco J Blanco6, 1Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Rheumatology Research Group, Proteomics Unit-ProteoRed/ISCIII, INIBIC-CHUAC, A Coruña, Spain, 3Proteomics group, Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña, La Coruña, Spain, 4Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 5School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom, 6Rheumatology Divison, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by high clinical variability and an underlying cellular and molecular heterogeneity. Efforts to find tools for the classification of…
  • Abstract Number: 2949 • 2018 ACR/ARHP Annual Meeting

    African American and European American SLE Patients with Variable Disease Activity Reveal Distinct Differences in B Cells and TLR7/8 Pathways

    Samantha Slight-Webb1, Miles C. Smith1, Holden T. Maecker2, Paul J. Utz3, Joel M. Guthridge1 and Judith A. James4, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Stanford University, Stanford, CA, 3Medicine, Stanford University School of Medicine, Stanford, CA, 4Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disorder with a heterogeneous clinical presentation and periods of waxing and waning disease. Heterogeneity in SLE is…
  • Abstract Number: 2574 • 2017 ACR/ARHP Annual Meeting

    Interleukin-33 Ameliorates Murine Lupus Via Induction of Regulatory T Cells and M2 Macrophage Polarisation

    Mo Yin Mok1, Ka Sin Law2, Wing Yin Kong1, Ge Liu1, Wallace Lau2, C Luo2, FP Huang3, GC Chan4 and Kwok Wah Chan3, 1Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, Hong Kong, 2Department of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong, 3Department of Pathology, University of Hong Kong, Hong Kong, Hong Kong, 4Department of Paediatrics, University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: The levels of IL-33, a Th2 promoting cytokine, and the soluble form of its receptor ST2 were reported to be elevated in serum of…
  • Abstract Number: 1639 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Evolution in a Nationwide Cohort Originally Classified As Mixed Connective Tissue Disease

    Silje Reiseter1, Ragnar Gunnarsson2, Jukka Corander3, Johanna Haydon4, May Brit Lund5 and Øyvind Molberg1, 1Oslo University Hospital, Oslo, Norway, 2Department of Rheumatology, Oslo University Hospital, Oslo, Norway, OSLO, Norway, 3Departement of Biostatistics, University of Oslo, Oslo, Norway, 4Rheumatology, Vestre Viken Hospital, Drammen, Norway, 5Respiratory Medicine, Oslo University Hospital, Oslo, Norway

    Background/Purpose: Ever since Mixed Connective Tissue Disease was presented as a distinct entity in 1972, it has been discussed whether MCTD represents an undifferentiated, transient…
  • Abstract Number: 125 • 2016 ACR/ARHP Annual Meeting

    Increased Hypertension and Renal Disease in African Americans Compared to Caucasians with Systemic Lupus Erythematosus

    April Barnado1, Robert Carroll2, Carolyn Casey1, Joshua C. Denny2 and Leslie J. Crofford3, 1Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 3Medicine, Vanderbilt University Medical Center, Nasville, TN

    Background/Purpose: African Americans have higher rates of SLE and SLE nephritis compared to Caucasians. These epidemiologic associations come mainly from cohort studies that collect standardized…
  • Abstract Number: 2879 • 2016 ACR/ARHP Annual Meeting

    Genome-Wide Pathway Analysis Reveals That VEGF Genetic Pathway Is Associated with Oral Ulcers in Systemic Lupus Erythematosus

    Antonio Julià1, Patricia Carreira2, Ricardo Blanco3, Victor Martinez Taboada4, Luis Carreño5, Jose Javier Perez Venegas6, Alejandro Olivé7, Jose Luis Andreu8, Maria Ángeles Aguirre Zamorano9, Paloma Vela10, Joan Miquel Nolla11, José Luis Marenco de la Fuente12, Antonio Zea13, JM Pego-Reigosa14, Mercedes Freire15, Elvira Diez Alvarez16, Adrìa Aterido1, Arnald Alonso1, Maria López-Lasanta17, Mireia López18, Raül Tortosa1, Sara Marsal19 and Antonio Fernandez-Nebro20, 1Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 2Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 4Hospital Marqués de Valdecilla., Santander, Spain, 5Rheumatology, HGU Gregorio Marañón, Madrid, Spain, 6Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, 7Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, 8Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 9Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 10Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 11Rheumatology, Bellvitge University Hospital, Barcelona, Spain, 12Rheumatology, Hospital de Valme, Seville, Spain, 13Hospital Ramón y Cajal. Madrid, Madrid, Spain, 14Rheumatology Section, Hospital de Meixoeiro, Pontevedra, Spain, Vigo, Spain, 15Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 16Rheumatology, Hospital de León, León, Spain, 17Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 18Servicio de Reumatología, Hospital Universitario Vall d´Hebron, Barcelona, Spain, 19Rheumatology Research Unit, Vall d'Hebron Hospital, Barcelona, Spain, 20Rheumatology, Hospital Universitario Carlos Haya, Malaga, Spain

    Background/Purpose: Systemic lupus erythematosus (SLE) is a genetically complex rheumatic disease with heterogeneous clinical manifestations. Recent studies have suggested the existence of a genetic basis…
  • Abstract Number: 797 • 2015 ACR/ARHP Annual Meeting

    Divergent Phenotypic Patterns Between Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive Individuals Reveal Distinct Differences in B Cell and Myeloid Populations Among Ethnicities

    Samantha Slight-Webb1, Rufei Lu2, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge1 and Judith A. James5, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disorder that arises from genetic and environmental factors. Thus, patients with different ancestral backgrounds display differences in…
  • Abstract Number: 2200 • 2015 ACR/ARHP Annual Meeting

    Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository Cluster Analysis: Identification of Different Clinical Phenotypes Among Antiphospholipid Antibody-Positive Female Patients

    Stephane Zuily1, Cecilia B. Chighizola2, DENIS WAHL1, Pier Luigi Meroni3 and Doruk Erkan4, 1CHU de Nancy, Vascular Medicine Division and Regional Competence Centre For Rare Vascular And Systemic Autoimmune Diseases; and UMR_S U1116 Research Unit, France, Nancy, France, 2Department of Clinical Sciences and Community Health, University of Milan, Istituto Auxologico Italiano, Cusano Milanino, Italy, 3University of Milan, Department of Clinical Sciences and Community Health, Division of Rheumatology, Gaetano Pini Institute, Milan, Italy, 4Barbara Volcker Center for Women & Rheumatic Disease, Hospital for Special Surgery, New York, NY

    Background/Purpose: APS ACTION International Clinical Database and Repository was created to study the natural course of persistently antiphospholipid antibodies (aPL)-positive patients ± autoimmune disorders over…
  • Abstract Number: 2697 • 2015 ACR/ARHP Annual Meeting

    Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia

    Jayanth Doss1, Huan Mo2, Leslie J. Crofford1 and Joshua C. Denny2, 1Rheumatology, Vanderbilt University School of Medicine, Nashville, TN, 2Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN

    Background/Purpose: The differences between seronegative and seropositive rheumatoid arthritis (RA) have not been widely reported. We performed an electronic health record (EHR)-based phenome-wide association study…
  • Abstract Number: 1718 • 2014 ACR/ARHP Annual Meeting

    B Cell Subsets Homeostasis and Functional Properties Are Altered in a Murine Model of Systemic Sclerosis

    Sébastien Sanges1,2,3, Niloufar Kavian4, Carine Hauspie1,3,5, Carole Nicco4, Thomas Guerrier1,3, Virginie Dutoit-Lefèvre1,3, Guillaume Lefèvre1,2,5,6, Alexandra Forestier1,2,3, Vincent Sobanski1,2,6, Christelle Faveeuw7, Myriam Labalette1,3,5, Frédéric Batteux4, David Launay1,2,3 and Sylvain Dubucquoi1,3,5, 1Université Lille Nord de France, Faculté de Médecine Henri Warembourg, Lille, Lille, France, 2Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 3EA 2686, Lille, Lille, France, 4Université Paris Descartes, EA 1833, Hôpital Cochin, AP-HP, Paris, Paris, France, 5Institut d’Immunologie, Centre de Biologie-Pathologie-Génétique, CHRU Lille, Lille, France, 6EA 2686, Lille, LILLE, France, 7Institut National de la Santé et de la Recherche Médicale Unité 547, Institut Pasteur de Lille, Institut Fédératif de Recherche 142, Université de Lille Nord de France, Lille, France

    Background/Purpose Systemic sclerosis (SSc) is a multi-organ fibrotic disease associated with auto-immune abnormalities. Several clinical and experimental observations suggest that B cells are involved in…
  • Abstract Number: 835 • 2014 ACR/ARHP Annual Meeting

    Relapsing Polychondritis Can be Characterized By 3 Different Clinical Phenotypes: Analysis of a Series of 142 Patients

    Jeremie Dion1, Nathalie Costedoat-Chalumeau1, Damien Sène2, Judith Cohen-Bittan3, Gaëlle Leroux4, Charlotte Dion5, Camille Francès6 and Jean-Charles Piette7, 1Internal medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 2Hopital Lariboisière, service de Médecine Interne, Paris, France, 3Service de medecine gériatrique, CHU Pitié-Salpêtrière, Paris, France, 4Department of Internal Medicine 1, CHU Pitié-Salpêtrière, Paris, France, 5Ecole des hautes études en sciences sociales, Paris, France, 6service de dermatologie allergologie, Hôpital Tenon, Paris Cedex 20, France, 7Department of Internal Medicine 1., CHU Pitié-Salpêtrière, Paris, France

    Background/Purpose We previously described clinical characteristics and evolution of 142 patients with relapsing polychondritis (RP) followed in a single center and seen at least once…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology